BioCentury
ARTICLE | Clinical News

ACPC: Started Phase I trial

February 14, 1994 8:00 AM UTC

Symphony Pharmaceuticals Inc. , Philadelphia Product: ACPC, partial glutamate agonist Indication: Neuroprotection in coronary artery bypass graft surgery patients Status: Started Phase I trial in heal...